Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever
- PMID: 11454890
- DOI: 10.1200/JCO.2001.19.14.3415
Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever
Abstract
Purpose: To identify clinical and laboratory parameters present at the time of a first evaluation that could help predict which children with cancer, fever, and neutropenia were at high risk or low risk for an invasive bacterial infection.
Patients and methods: Over a 17-month period, all children with cancer, fever, and neutropenia admitted to five hospitals in Santiago, Chile, were enrolled onto a prospective protocol. Associations between admission parameters and risk for invasive bacterial infection were assessed by univariate and logistic regression analyses.
Results: A total of 447 febrile neutropenic episodes occurred in 257 children. Five parameters were statistically independent risk factors for an invasive bacterial infection. Ranked by order of significance, they were as follows: C-reactive protein levels of 90 mg/L or higher (relative risk [RR], 4.2; 95% confidence interval [CI], 3.6 to 4.8); presence of hypotension (RR, 2.7; 95% CI, 2.3 to 3.2); relapse of leukemia as cancer type (RR, 1.8, 95% CI, 1.7 to 2.3); platelet count less than or equal to 50,000/mm(3) (RR, 1.7; 95% CI, 1.4 to 2.2); and recent (< or = 7 days) chemotherapy (RR, 1.3; 95% CI, 1.1 to 1.6). Other previously postulated risk factors (magnitude of fever, monocyte count) were not independent risk factors in this study population.
Conclusion: In a large population of children, common clinical and laboratory admission parameters were identified that can help predict the risk for an invasive bacterial infection. These results encourage the possibility of a more selective management strategy for these children.
Comment in
-
Risk factors in children with fever and neutropenia.J Clin Oncol. 2001 Nov 15;19(22):4270-1. doi: 10.1200/JCO.2001.19.22.4270. J Clin Oncol. 2001. PMID: 11709573 No abstract available.
Similar articles
-
Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia.Clin Infect Dis. 2002 Sep 15;35(6):678-83. doi: 10.1086/342064. Epub 2002 Aug 23. Clin Infect Dis. 2002. PMID: 12203164
-
Admission clinical and laboratory factors associated with death in children with cancer during a febrile neutropenic episode.Pediatr Infect Dis J. 2007 Sep;26(9):794-8. doi: 10.1097/INF.0b013e318124aa44. Pediatr Infect Dis J. 2007. PMID: 17721373
-
A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia.J Pediatr Hematol Oncol. 2006 Oct;28(10):665-70. doi: 10.1097/01.mph.0000212996.94929.0b. J Pediatr Hematol Oncol. 2006. PMID: 17023827
-
Risk assessment in fever and neutropenia in children with cancer: What did we learn?Crit Rev Oncol Hematol. 2009 Oct;72(1):45-55. doi: 10.1016/j.critrevonc.2008.12.009. Epub 2009 Feb 4. Crit Rev Oncol Hematol. 2009. PMID: 19195908 Review.
-
Evolving concepts of management of febrile neutropenia in children with cancer.Med Pediatr Oncol. 2002 Aug;39(2):77-85. doi: 10.1002/mpo.10073. Med Pediatr Oncol. 2002. PMID: 12116054 Review.
Cited by
-
The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia.Support Care Cancer. 2011 Oct;19(10):1593-600. doi: 10.1007/s00520-010-0987-6. Epub 2010 Aug 28. Support Care Cancer. 2011. PMID: 20803037 Free PMC article.
-
Update on Febrile Neutropenia in Pediatric Oncological Patients Undergoing Chemotherapy.Children (Basel). 2021 Nov 25;8(12):1086. doi: 10.3390/children8121086. Children (Basel). 2021. PMID: 34943282 Free PMC article. Review.
-
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT.Health Technol Assess. 2024 Mar;28(14):1-101. doi: 10.3310/RGTP7112. Health Technol Assess. 2024. PMID: 38512064 Free PMC article. Clinical Trial.
-
Hyperpyrexia and high fever as a predictor for serious bacterial infection (SBI) in children-a systematic review.Eur J Pediatr. 2018 Mar;177(3):337-344. doi: 10.1007/s00431-018-3098-x. Epub 2018 Jan 31. Eur J Pediatr. 2018. PMID: 29387980
-
Serum lactate is associated with increased illness severity in immunocompromised pediatric hematology oncology patients presenting to the emergency department with fever.Front Oncol. 2022 Oct 6;12:990279. doi: 10.3389/fonc.2022.990279. eCollection 2022. Front Oncol. 2022. PMID: 36276165 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials